Lonza Announces Cells on Demand™ – Cell Culture and Transfection Services

Lonza announces the launch of Cells on Demand™ Cell Culture and Transfection Services, a new offering providing researchers assay ready cells for cell based screening, including primary cells, cell lines, stable clones, transiently transfected cells and media.

“Cells on Demand™ has been designed to deliver customers high quality cells, on-time and to specification. Customers can focus on their research, rather than spending time troubleshooting cell production issues and inefficient transfection protocols,” said said Dr. Marin Parenty, Head of Lonza Cell Discovery. “Also, this program provides researchers with access to Lonza’s decades of experience in cell culture of both primary cells and cell lines as well as industry leading expertise in non-viral transfection.”

Lonza’s Cells on Demand™ services include:
• Bulk cell production - large scale manufacturing of cell lines, transfected cells, and primary cells including Clonetics® primary cells and Poietics® stem cells
• Transfection services – expertise with Amaxa® Nucleofector® Technology in generating stable clones and transiently transfected cells, Nucleofection® Protocol Optimization, and small scale protein production
• Cell isolation services - laboratory is ISO 9001 certified with expertise in 50+ cell types from a variety of species
• Media production - classical or specialty, including serum free & chemically defined
Lonza is a leader in cell culture and transfection technology and has a broad range of trusted products used in industry and academia.